期刊文献+

氯诺昔康用于髋关节置换术后静脉镇痛的效果观察

Postoperative Continuous Intravenous Analgesia with Lornoxicam in Patients with Hip Arthroplasty Surgery
暂未订购
导出
摘要 目的:探讨氯诺昔康用于髋关节置换术后静脉镇痛的临床疗效及不良反应。方法:60例ASAⅠ-Ⅲ级全髋关节置换或半关节置换术患者随机分为两组:L组(氯诺昔康组)和M组(吗啡组),每组30例。L组采用氯诺昔康72 mg加0.9%氯化钠注射液稀释至96 mL,M组采用吗啡80 mg加0.9%氯化钠注射液稀释至96 mL。手术结束后1、2、4、8、24、48 h各时段采用视觉模拟评分(VAS)及舒适评分(BCS)评估两组镇痛效果及不良反应。结果:L组VAS、BCS与M组之间差异均无统计学意义(P均>0.05);M组头晕、恶心、呕吐、皮肤骚痒及尿潴留均高于L组(P均<0.05)。结论:氯诺昔康与吗啡用于髋关节置换术后静脉镇痛效果相当,但使用氯诺昔康静脉镇痛的不良反应较少。 Objective: To assess the analgesic effects of continuous intravenous analgesia with lornoxicam in patients with orthopedic surgery. Methods:Sixty patients undergoing orthopedic surgery were divided into two groups: group L(lornoxicam group) and group M (morphine group) with 30 in each group. The patients in group L were given lornoxicam 72 mg diluted to 96 mL with 0.9 % Sodium Chloride, background dose was 2 mL/h;The patients in group M were given morphine 80 mg diluted to 96 mL with 0.9% Sodium Chloride, background dose was 2 mL/h. Visual analogue pain scale (VAS)and Bruggman comfort score (BCS) were observed at 1,2,4,24,48 h after operation. Resuhs:VAS and BCS were no significant differences between two groups in every time after operation (P〈0.05). The adverse events such as nausea,vomiting and urinary retention in group L were markedly lower Lhan those of group M (P〈0.05). Conclusion. Lornoxicam used for postoperation analgesia could provide similar analgesic efficacy with morphine injection for patients undergoing orthopedic surgery, but there were little adverse events.
出处 《实用临床医学(江西)》 CAS 2007年第2期52-53,58,共3页 Practical Clinical Medicine
关键词 氯诺昔康 静脉镇痛 髋关节置换术 Iornoxicam continuous intravenous analgesia hip arthroplasty surgery
  • 相关文献

参考文献5

二级参考文献21

  • 1洪梅,宋善俊.外科危重病凝血功能障碍的监测及治疗[J].中国实用外科杂志,1996,16(12):724-726. 被引量:5
  • 2[1]Nuutinen LS,Laitinen JO,Salomaki TE.A risk-benefit appraisal of injectable NSAIDs in the management of postoperative pain[J].Drug Safety,1993,9(5)∶380-393.
  • 3[2]Staunstrup H,Ovesen J,et al.Efficacy and tolerability of lornoxicam versus tramadol in postoperative pain[J].Clin Pharmacol,1999,39(8)∶834-841.
  • 4[3]Moote C.Efficacy of nonsteroidal anti-inflammatory drugs in the manegement of postoperative pain[J].Drugs,1992,44(Suppl 5)∶14-30.
  • 5[4]Schug SA,large RG.Economic considerations in pain manegement by an acute pain service[J].Pharmacoeconomics,1993,3(4)∶260-267.
  • 6[1]Rosenow DE, Albrechtsen M, Stolk D. A Comparison of patient-controlled analgesia with lornoxicam versus morphine in patients undergoing lumbar disk surgery. Anesth & Analg, 1998,86: 1045 ~ 1050.
  • 7[2]Rosenow DE, Van Krieken F, Kursten FW. Intravenous administration of lornoxicam, a new NSAID, and pethidine for postoperative pain. A placebo-controlled pilot study. Clinical Drug Investigation, 1996, 11:11~19.
  • 8[5]Agency for Health Care Policy and Research. Acute pain management: operative or medical procedures and trauma-part 1. Clin Pharmacol, 1992,11 : 309~331.
  • 9[6]Kehlet H, Dahl JB. The Value of "multimodal" or "balanced analgesia" in postoperative pain treatment. Anaesth Analg, 1993,77: 1048~ 1056.
  • 10[7]Moote C. Efficacy of nonsteroidal anti-inflammatory drugs in the management of postoperative pain.Drugs, 1992, 44 Suppl. 5: 14 ~ 30.

共引文献102

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部